Top

Gepubliceerd in:

01-06-2007 | debate article

Periodical cardiovascular screening is mandatory for elite athletes

Pro screening

Auteurs: H. Inklaar, N. M. Panhuyzen-Goedkoop

Gepubliceerd in: Netherlands Heart Journal | Uitgave 6/2007

Abstract

Sudden cardiac death (SCD) of an athlete is a very tragic event. When it concerns a well-known elite sportsman, it creates much publicity. Inevitably questions are raised about the health-promoting value of sports and the necessity of a mandatory periodical cardiovascular screening to prevent sports-related cardiac events. In order to answer the final question many aspects of SCD and screening in general have to be addressed.

vorige artikel ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy

volgende artikel Periodical cardiovascular screening is mandatory for elite athletes

26th Bethesda Conference. Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Am J Coll Cardiol 1994;24:845-99 and Med Sci Sports Exerc 1994;26:S223-S283.

Whithby LG. Screening for disease, Definitions and criteria. Lancet 1974;333:819-21.

Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-4.

Bille K, Figueiras D, Schamash P, Kappenberger, Brenner JI, Meijboom FJ, et al. Sudden cardiac death in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehab 2006;13:1-17.

Corrado D, Pellicia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:16-24.

Dolmans AJ, Pool J, Erdman-Trip JF, Smit B, Lubsen J. Het risico van overlijden bij sport. Ned Tijdschr Geneeskd 1984;128:595-8.

Deligiannis A, Bjornstad H, Carre F, Heidbuchel H, Kouidi E, Panhuyzen-Goedkoop NM, et al. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehab 2006;13:687-94.

Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the sudden death committee (clinical cardiology) and congenital cardiac defects committee (cardiovascular disease in young), American Heart Association. Circulation 1996;94:850-6.

Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program. JAMA 2006;296:1593-601.

Corrado D, Basso C, Schiavon, Thiene G. Identification of athletes with hypertrophic cardiomyopathy at risk of sudden death: cost-effectiveness analysis of screening strategies. Circulation 2002;106 (abstract): II-701.

Elliott P, Mckenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881-91.

Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-80.

Corrado D, Pellicia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26: 516-24.

Gezondheidsraad. Jaarbericht bevolkingsonderzoek Den Haag: Gezondheidsraad, 2006; publicatie nr 2006/10.

Panhuyzen-Goedkoop NM, Pluim BM, Senden PJ, Hoogsteen J, Bennekers H, Inklaar H, et al. Preventie van plotse dood in de sport bij jonge atleten in Nederland (consensusdocument). Geneesk en Sport 2005;38:107-12.

Tanaka Y, Yoshinaga M, Anan R, Tanaka Y, Nomura Y, Oku S, et al. Usefulness and cost effectiveness of cardiovascular screening of young athletes. Med Sci Sports Exerc 2006;38:2-6.

Tan HL, Hofmans N, Langen van IM, Wal van der AC, Wilde AA. Sudden unexplained death: Heritability and Diagnostic Yield of Cardiological and Genetic Examination in Surviving Relatives. Circulation 2005;112:207-13.

Pellicia A, Maron BJ, Culasso F, Di Paolo FM, Spataro A, Biffi A, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.

Titel: Periodical cardiovascular screening is mandatory for elite athletes
Pro screening
Auteurs: H. Inklaar
N. M. Panhuyzen-Goedkoop
Publicatiedatum: 01-06-2007
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 6/2007
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03085984

Andere artikelen Uitgave 6/2007